期刊文献+

尿脱落细胞端粒酶催化亚基mRNA检测在膀胱癌诊断和监测复发中的意义 被引量:1

Detection of hTERT mRNA expression in urine exfoliated cells and its significance in diagnosing bladder cancer and monitoring recurrence
下载PDF
导出
摘要 目的探讨尿脱落细胞端粒酶催化亚基(human telomerase reverse transcriptase,hTERT)mRNA检测在膀胱癌早期诊断和监测复发中的应用价值。方法采用逆转录聚合酶链反应(reverse transcriptase PCR,RT-PCR)检测42例膀胱癌、38例膀胱良性疾病患者和12例健康体检者晨尿中脱落细胞hTERT mRNA的表达,并与尿脱落细胞学检查结果比较;随访观察其中37例膀胱癌术后尿液hTERT mRNA变化与复发的关系。结果hTERT检测膀胱癌的敏感性为97.62%,显著高于尿脱落细胞学检测的61.9%(P<0.05);特异性为96%,与尿脱落细胞学检测98%无明显差异(P>0.05);膀胱癌患者术前hTERT mR-NA表达强度明显高于膀胱良性疾病患者和对照组(P<0.05);且随肿瘤恶性程度的增加逐渐升高,G1、G2、G3(WHO分级)患者hTERTmRNA表达强度分别为0.63±0.14、0.75±0.16、0.87±0.20。结论尿脱落细胞hTERT mRNA检测具有高度敏感和特异性,对膀胱癌早期诊断、疗效评估和术后监测复发具有重要的临床应用价值。 Objective To evaluate the significance of detection of human telomerase reverse transcriptase (hTERT) mRNA expression in urine exfoliated cells for the diagnosis and postoperative monitoring of bladder cancer recurrence. Methods The middle and later urine voided firstly in the morning were collected from 42 patients with bladder cancer, 38 patients with bladder benign lesions and 12 healthy controls. RT-PCR was performed for the hTERT mRNA in urine exfoliated cells. The cytologic analysis was carried out simultaneously, and the two detection results were compared. 37 postoperative patients among them were followed up to study the relations between hTERT mRNA expression with recurrence. Results The detection of hTERT mRNA expression in urine exfoliated cells had higher sensitivity (97.62%) than that of cytologic analysis (61.9 %) (P〈0.05), and their specificity was not significantly different. The expression intensity of hTERT mRNA in urine exfoliated cells from preoperative patients with bladder cancer were greater than that from patients with bladder benign lesions and healthy controls (P 〈0.05), and the expression intensity in higher grade bladder cancer was greater compared with that in lower grade cancer(P〈0.05). The expression intensity of hTERT mRNA in urine exfoliated cells from patients with bladder cancer at G1, G2 and G3 were 0. 635±0.14, 0.75 5±0.16 and 0.87±0.20. Conclusion hTERT mRNA detection by RT-PCR has higher sensitivity and specificity, and has potential value for the early diagnosis and postoperative monitoring of bladder cancer recurrence.
出处 《现代泌尿外科杂志》 CAS 2008年第2期114-116,共3页 Journal of Modern Urology
关键词 膀胱癌 端粒酶催化亚基 尿脱落细胞 逆转录聚合酶链反应 bladder cancer human telomerase reverse t ranscriptase exfoliated cells in urine RT-PCR
  • 相关文献

参考文献7

二级参考文献19

  • 1奚伟红,倪晓谦,沈玉琴,黄琴梅.胃癌端粒酶活性临床研究[J].世界华人消化杂志,2000,8(z1). 被引量:2
  • 2Gelmini S,Crisci A,Salvadori B,et al.Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings,using a quantitative assay.Clin Cancer Res,2000,6:2771-2776.
  • 3Ramakumar S,Bhuiyan J,Besse JA,et al.Comparison of scree-ning methods in the detection of bladder cancer.J Urol,1999,161:388-394.
  • 4Wu XX,Kakehi Y,Takahashi T,et al.Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.Int J Urol,2000,7:210-217.
  • 5Zhang X,Gene & Development,1999年,13卷,18期,2388页
  • 6Zeiger M A,Surgery,1999年,126卷,6期,1195页
  • 7Meyerson M,Cell,1997年,90卷,4期,785页
  • 8Lin Y,Clin Cancer Res,1996年,2卷,6期,929页
  • 9Xi Weihong(奚伟红),Ni Xiaoqian(倪晓谦).Telomerase activi-ty and cancer."ACCP",Program&Abstract,1998,10~94.
  • 10Xi Weihong(奚伟红),Ni Xiaoqian(倪晓谦).The clinical study of telomerase activity in gastric tumor. U. S. Chinese Journal of Medicine, 2001, 7(2):12~13.

共引文献27

同被引文献9

  • 1马鹏程,赵达.端粒酶活性在泌尿系统恶性肿瘤组织中的表达及临床意义[J].兰州大学学报(医学版),2005,31(1):27-29. 被引量:2
  • 2Van Rhijin BW,Van der Poel HG,Van der Kwast TH. Urine markers for bladder cancer surverillance: a systematic review [ J ]. Eur Urol, 2005,47 ( 6 ) : 736 -748.
  • 3Konety BR. Molecular markeres in bladder cancer. A critical appraisal [ J ]. Urol Onco1,2006,24 (4) :326-327.
  • 4Fernandez-Gomez J, Rodriguez-Martnez JJ, Barmadah SE, et al. Urina- ry CYFRA21.1 is not a useful marker for the detection of recurrences in the follow-up of superficical bladder cancer[ J ]. Eur Urol,2007,51 (5) : 1267-1274.
  • 5Sharial SF, Ashfag R, Karakiewicz PI, et al. Survivin expression is as- sociated with bladder cancer presence, stage progression and mortality [ J ]. Cancer,2007,109 (6) : 1106-1113.
  • 6Bravaccini S, Sanchini MA, Granato AM, et al. Urine telomerase activi- ty for the detection of bladder cancer in females [ J ]. Urol,2007,178 ( 1 ) :57-61.
  • 7Sanchini MA, Gunelli R, Nanni O, et al. Releveance of Urine telomer- ase in the diagnosis of bladder cancer [ J ]. JAMA, 2005,294 ( 16 ) : 2052-2056.
  • 8汪强武,燕善军,刘会春,王启之,周磊,张恒,姚爱群.胰、胆管梗阻病变中脱落细胞端粒酶活性的测定[J].中华全科医学,2008,6(11):1123-1124. 被引量:4
  • 9杨国良,薄隽杰.尿液中膀胱肿瘤标志物检测的研究进展[J].中国癌症杂志,2009,19(7):557-561. 被引量:11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部